All In Biotech

Free tool

FAERS Monitor: Gemcitabine Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 200795 or its brand name (Gemcitabine Hydrochloride, Gemcitabine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

54,066

Serious

52,517

97% of reports

Hospitalization

21,422

Death reported

10,141

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • disease progression4,940
  • off label use4,270
  • thrombocytopenia3,805
  • neutropenia3,364
  • anaemia3,158
  • malignant neoplasm progression2,987
  • drug ineffective2,831
  • nausea2,657
  • pyrexia2,636
  • diarrhoea2,167
  • fatigue2,151
  • vomiting2,149
  • death2,024
  • febrile neutropenia1,861
  • myelosuppression1,742

Reports by year received

View as table
YearReports
2004500
2005487
2006551
2007345
2008422
2009596
2010541
20111,057
20121,514
20131,282
20141,550
20152,451
20162,925
20172,848
20183,272
20193,801
20203,649
20213,581
20224,151
20235,189
20244,905
20254,825
20263,624

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,093 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal1,74219.718.829,493
disease progressionSignal4,94016.916.571,225
thrombocytopeniaSignal3,80513.713.243,374
malignant neoplasm progressionSignal2,98711.711.328,382
febrile neutropeniaSignal1,86111.210.716,846
neutropeniaSignal3,3649.89.526,227
anaemiaSignal3,1586.56.314,681
pyrexiaSignal2,6363.02.93,494
off label use4,2701.91.81,894
vomiting2,1491.81.7750
nausea2,6571.31.3198
diarrhoea2,1671.31.3160
fatigue2,1511.11.012
death2,0240.90.917
drug ineffective2,8310.80.898

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.